Family and linkage study of selective IgA deficiency and common variable immunodeficiency. 1995

I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
Karolinska Institute at NOVUM, Center for BioTechnology, Huddinge, Sweden.

Screening of close relatives of Swedish patients with selective immunoglobulin A deficiency (IgAD) and common variable immunodeficiency (CVID) for serum immunoglobulin levels has identified the positive family history of IgAD/CVID as the most significant risk factor for developing the disease. The relative risk for siblings of patients with IgAD was estimated to be approximately 50. In 12 of 34 Swedish multiplex families identified in the study, both IgAD and CVID occurred, usually CVID in the parental generation and IgAD in the subsequent generation. This proportion was much higher than expected by chance and strongly suggests that the two clinically discernible disorders represent an allelic condition, reflecting a variable expressivity of a common defect. In 27 multiplex families the disorders segregated as an autosomal dominant trait, affecting at least two generations. A high relative risk for siblings, permanent phenotype, low number of phenocopies, and common population prevalence, which makes it possible to obtain a sufficient sample size, make these immunoglobin deficiencies amenable to genetic linkage analysis. In a pilot multicenter linkage study involving 16 multiplex families with dominant transmission of IgAD/CVID, we have attempted to confirm previously reported genetic linkage of the disease susceptibility to the major histocompatibility complex (MHC) region. Using both parametric and nonparametric linkage analyses with a set of microsatellite markers at and flanking the MHC region, no evidence for linkage was found. In accordance with these results, no evidence for linkage to the MHC region was obtained by analyzing previously published segregation data at the MHC region in multiplex families with IgAD/CVID in more than one generation.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D013548 Sweden Country in northern Europe, bordering the Baltic Sea, between Finland and Norway. The capital is Stockholm.
D017074 Common Variable Immunodeficiency Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections. Immunodeficiency, Common Variable,Common Variable Hypogammaglobulinemia,Common Variable Immune Deficiency,Hypogammaglobulinemia, Acquired,Immunoglobulin Deficiency, Late-Onset,Acquired Hypogammaglobulinemia,Acquired Hypogammaglobulinemias,Common Variable Hypogammaglobulinemias,Common Variable Immunodeficiencies,Deficiencies, Late-Onset Immunoglobulin,Deficiency, Late-Onset Immunoglobulin,Hypogammaglobulinemia, Common Variable,Hypogammaglobulinemias, Acquired,Hypogammaglobulinemias, Common Variable,Immunodeficiencies, Common Variable,Immunoglobulin Deficiencies, Late-Onset,Immunoglobulin Deficiency, Late Onset,Late-Onset Immunoglobulin Deficiencies,Late-Onset Immunoglobulin Deficiency,Variable Hypogammaglobulinemia, Common,Variable Hypogammaglobulinemias, Common
D017098 IgA Deficiency A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A. Deficiency, IgA,Deficiencies, IgA,IgA Deficiencies

Related Publications

I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
May 2000, Clinical and experimental immunology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
January 2008, International archives of allergy and immunology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
December 1982, Clinical immunology and immunopathology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
June 1997, Clinical immunology and immunopathology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
January 2015, Journal of investigational allergology & clinical immunology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
October 2000, Clinical reviews in allergy & immunology,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
January 2014, Allergologia et immunopathologia,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
September 2006, Current allergy and asthma reports,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
October 1999, Vnitrni lekarstvi,
I Vorechovský, and H Zetterquist, and R Paganelli, and S Koskinen, and A D Webster, and J Björkander, and C I Smith, and L Hammarström
August 2013, Mayo Clinic proceedings,
Copied contents to your clipboard!